Thrombosis of a bioprosthetic mitral valve under extracorporeal membrane oxygenation: thrombus formation in the left heart. 2012

Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
Heart and Cardiovascular Centre Nordrhein-Westfalen, Department of Cardiovascular Surgery, Bad Oeynhausen, Ruhr University Bochum, Germany. rgottfried@hdz-nrw.de

UI MeSH Term Description Entries
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D015199 Extracorporeal Membrane Oxygenation Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of SMOKE INHALATION INJURY; RESPIRATORY FAILURE; and CARDIAC FAILURE. ECMO Extracorporeal Membrane Oxygenation,Oxygenation, Extracorporeal Membrane,Venoarterial ECMO,Venoarterial Extracorporeal Membrane Oxygenation,Venovenous ECMO,Venovenous Extracorporeal Membrane Oxygenation,ECLS Treatment,ECMO Treatment,Extracorporeal Life Support,ECLS Treatments,ECMO Treatments,ECMO, Venoarterial,ECMO, Venovenous,Extracorporeal Life Supports,Extracorporeal Membrane Oxygenations,Life Support, Extracorporeal,Membrane Oxygenation, Extracorporeal,Treatment, ECLS,Treatment, ECMO,Venoarterial ECMOs,Venovenous ECMOs
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
April 2024, Perfusion,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
January 2019, Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
March 2017, Echo research and practice,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
March 2019, Journal of cardiothoracic and vascular anesthesia,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
June 2013, Korean circulation journal,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
April 2022, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
May 1993, Chest,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
December 2022, JA clinical reports,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
March 2024, Cureus,
Regine Gottfried, and Lech Paluszkiewicz, and Lukasz Kizner, and Michiel Morshuis, and Heinrich Koertke, and Jan Gummert
September 2018, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!